Analyst Ratings for Novo Nordisk (NVO) [Buys]
NVO Rating Summary
NVO Price Target Summary
- Highest: $163.00 (BMO Capital)
- Lowest: $115.00 (TD Cowen)
- Average: $140.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$140.40 (+11.6%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$140.40 (+11.6%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/12/2024 | BMO Capital | Evan David Seigerman | New Coverage | Outperform (N/A) |
163.00 (N/A) |
124.93 (125.79) |
0.69% | Details |
| 1/23/2024 | Morgan Stanley » Updated 4/15/2024 |
Mark Purcell | New Coverage | Overweight (N/A) |
139.00 (134.00) |
106.96 (125.79) |
17.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
